Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Duhem

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Hematology|February 1, 1996
Intravenous immune globulins and hypothermiaC Duhem, F Ries, M Dicato
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|January 1, 1994
[Apoptosis and cancer]C Duhem, F Ries, M Dicato
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|January 1, 1994
[Severe neutropenia in infectious mononucleosis]C Duhem, F Ries, M Dicato
Clinical and Experimental Immunology|July 1, 1994
Side-effects of intravenous immune globulinsC Duhem, M A Dicato, F Ries
Current Opinion in Oncology|July 11, 2000
Clinical benefit from erythropoietinM Dicato, C Duhem, G Berchem, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|January 1, 1997
[New diagnostic approaches to deep venous thrombosis]S Rauh, M Dicato, C Duhem, et al.
Cytokines, Cellular & Molecular Therapy|June 1, 1997
Multidrug resistance: molecular and clinical aspectsM Dicato, C Duhem, M Pauly, et al.
Seminars in Oncology|October 26, 2000
The biology of colorectal cancerM Dicato, G Berchem, C Duhem, et al.
Seminars in Oncology|November 28, 1997
Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancerF Ries, C Duhem, K Kleiber, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|December 2, 2000
Complications and hospitalisation--duration after chemoembolisation for liver metastasesS Rauh, C Duhem, F Ries, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Hematology|February 1, 1996
Intravenous immune globulins and hypothermiaC Duhem, F Ries, M Dicato
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|January 1, 1994
[Apoptosis and cancer]C Duhem, F Ries, M Dicato
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|January 1, 1994
[Severe neutropenia in infectious mononucleosis]C Duhem, F Ries, M Dicato
Clinical and Experimental Immunology|July 1, 1994
Side-effects of intravenous immune globulinsC Duhem, M A Dicato, F Ries
Current Opinion in Oncology|July 11, 2000
Clinical benefit from erythropoietinM Dicato, C Duhem, G Berchem, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|January 1, 1997
[New diagnostic approaches to deep venous thrombosis]S Rauh, M Dicato, C Duhem, et al.
Cytokines, Cellular & Molecular Therapy|June 1, 1997
Multidrug resistance: molecular and clinical aspectsM Dicato, C Duhem, M Pauly, et al.
Seminars in Oncology|October 26, 2000
The biology of colorectal cancerM Dicato, G Berchem, C Duhem, et al.
Seminars in Oncology|November 28, 1997
Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancerF Ries, C Duhem, K Kleiber, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|December 2, 2000
Complications and hospitalisation--duration after chemoembolisation for liver metastasesS Rauh, C Duhem, F Ries, et al.
Pageof 3